MDS Surgery – Diagnostic Biopsies and Surgical Port Placement at Moffitt Cancer Center in Tampa, FL
MDS surgery is unlike the surgical procedures used to treat most other cancers. Myelodysplastic syndromes do not produce solid tumors, so it’s not possible to remove abnormal cells from the body (as it is with other malignancies). However, patients may undergo certain surgical procedures as part of their diagnosis or treatment, depending on their specific conditions and medical history.
The two types of surgery used during MDS diagnosis and treatment are:
- A bone marrow biopsy – A needle is inserted into the bone marrow and a small sample is removed for further laboratory testing,
- Surgical placement of a port – A small venous access device (port) is placed underneath a patient’s skin so that blood products can be administered, blood can be drawn and antibiotics can be administered without the need for routine needle punctures.
At Moffitt Cancer Center in Tampa, our Malignant Hematology Program is one of the largest and most well-respected in the nation. With a team of specialists who each focus on one specific aspect of treatment, such as chemotherapy, stem cell transplantation, supportive care or surgery, our MDS treatment team provides patients with access to a number of expert opinions under one roof. And, while many patients are referred to us by physicians and hematologists throughout the community, we also welcome patients who do not have referrals but wish to speak with a specialist.
For more information about MDS surgery in Tampa, Florida, call 1-888-663-3488 or submit a new patient registration form online.
Myelodysplastic Syndromes (MDS)
- Adrenal Cancer
- Anal Cancer
- Appendiceal (Appendix) Cancer
- Astrocytoma
- Basal Cell Carcinoma
- Bladder Cancer
- Bone Metastasis
- Brain Cancer
- Brain Tumor
- Breast Cancer
- Cervical Cancer
- Cholangiocarcinoma (Bile Duct Cancer)
- Colon Cancer
- Colorectal Cancer
- Cutaneous Lymphoma (CTCL)
- Ductal Carcinoma In Situ
- Endometrial (Uterine) Cancer
- Esophageal Cancer
- Gallbladder Cancer
- Gastrointestinal Carcinoid Tumor
- GIST (Gastrointestinal Stromal Tumor)
- Glioblastoma
- Head and Neck Cancer
- HER2 Positive Breast Cancer
- Hodgkin Lymphoma
- Inflammatory Breast Cancer
- Invasive Ductal Carcinoma
- Kidney (Renal Cell) Cancer
- Leukemia
- Liver (Hepatocellular) Cancer
- Low-Grade Glioma
-
Lung Cancer
- Signs and Symptoms
- Diagnosis
- Treatment
- FAQs
- Lung Cancer Early Detection Center
- Lung Cancer Screening and Surveillance Program
- Lung Nodules
- Lung Surveillance Clinic
- Metastatic Lung Cancer
- Recurrence
- Survival Rate
- Your Lung Cancer Specialists
- Lung and Thoracic Tumor Education (LATTE)
- Thoracic Clinic Updates
- Insurance & Financial Information
- Lymphomas (Hodgkin and Non-Hodgkin)
- Melanoma
- Meningioma
- Merkel Cell Carcinoma
- Mesothelioma
- Metastatic Breast Cancer
- Multiple Myeloma-Plasma Cell Tumor
- Myelodysplastic Syndromes (MDS)
- Neuroendocrine Tumor
- Neurofibromatosis
- Non-Hodgkin Lymphoma
- Oral Cavity (Mouth) Cancer
- Oral Cavity or Throat Cancer
- Osteosarcoma
- Ovarian Cancer
- Pancoast Tumor
- Pancreatic Cancer
- Penile Cancer
- Pituitary Adenoma
- Prostate Cancer
- Rectal Cancer
- Sarcoma
- Skin Cancer (Nonmelanoma)
- Skull Base Tumors
- Small Intestine Cancer
- Spinal Tumor
- Squamous Cell Carcinoma
- Stomach (Gastric) Cancer
- Testicular Cancer
- Throat Cancer
- Thymoma
- Thyroid Cancer
- Tongue Cancer
- Tracheal Cancer
- Triple Negative Breast Cancer
- Vaginal Cancer
- Vulvar Cancer